Endologix (ELGX) Misses Q2 EPS by 5c

Go back to Endologix (ELGX) Misses Q2 EPS by 5c

Piper Jaffray Cuts Price Target on Endologix (ELGX) to $20 Following 2Q15

August 4, 2015 8:29 AM EDT

Piper Jaffray maintained an Overweight rating on Endologix (NASDAQ: ELGX), and cut the price target to $20.00 (from $21.00), following 2Q15 results. Endologix reported revenues of $39.5M, just ahead of consensus $39.4M.

Analyst Brooks West commented, "Endologix reported 2Q15 revenues of $39.5M (+8%cc) just ahead... More

Canaccord Genuity Downgrades Endologix (ELGX) to Hold

August 4, 2015 7:03 AM EDT

Canaccord Genuity downgraded Endologix (NASDAQ: ELGX) from Buy to Hold with a price target of $14.00 (from $18.50).

For an analyst ratings summary and ratings history on Endologix click here. For more ratings news on Endologix click here.

Shares of Endologix closed at $14.06 yesterday.

... More